{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:16:53Z","timestamp":1791206213399,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1038\/nrneph.2010.155","type":"journal-article","created":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T10:51:46Z","timestamp":1290509506000},"page":"23-35","source":"Crossref","is-referenced-by-count":170,"title":["New insights into postrenal transplant hemolytic uremic syndrome"],"prefix":"10.1038","volume":"7","author":[{"given":"Julien","family":"Zuber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moglie","family":"Le Quintrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sberro-Soussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"key":"BFnrneph2010155_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00467-002-0936-9","volume":"17","author":"JR Ferraris","year":"2002","unstructured":"Ferraris, J. R. et al. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation. Pediatr. Nephrol. 17, 809\u2013814 (2002).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010155_CR2","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00467-003-1289-8","volume":"18","author":"C Loirat","year":"2003","unstructured":"Loirat, C. & Niaudet, P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr. Nephrol. 18, 1095\u20131101 (2003).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010155_CR3","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris, M. & Remuzzi, G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 361, 1676\u20131687 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2215\/CJN.00050505","volume":"1","author":"E Bresin","year":"2006","unstructured":"Bresin, E. et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin. J. Am. Soc. Nephrol. 1, 88\u201399 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli, J. et al. Genetics of HUS: the impact of, MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108, 1267\u20131279 (2006).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2006-939771","volume":"32","author":"D Kavanagh","year":"2006","unstructured":"Kavanagh, D. & Goodship, T. H. Membrane cofactor protein and factor I: mutations and transplantation. Semin. Thromb. Hemost. 32, 155\u2013159 (2006).","journal-title":"Semin. Thromb. Hemost."},{"key":"BFnrneph2010155_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/ng912","volume":"31","author":"MC Pickering","year":"2002","unstructured":"Pickering, M. C. et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 31, 424\u2013428 (2002).","journal-title":"Nat. Genet."},{"key":"BFnrneph2010155_CR8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1084\/jem.20070301","volume":"204","author":"MC Pickering","year":"2007","unstructured":"Pickering, M. C. et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J. Exp. Med. 204, 1249\u20131256 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2010155_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","volume":"15","author":"MA Dragon-Durey","year":"2004","unstructured":"Dragon-Durey, M. A. et al. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J. Am. Soc. Nephrol. 15, 787\u2013795 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR10","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc, A. L. et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 18, 2392\u20132400 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ki.2009.472","volume":"77","author":"F Bienaime","year":"2010","unstructured":"Bienaime, F. et al. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Int. 77, 339\u2013349 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2010155_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","volume":"12","author":"J Caprioli","year":"2001","unstructured":"Caprioli, J. et al. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J. Am. Soc. Nephrol. 12, 297\u2013307 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1681\/ASN.2005010086","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris, M. et al. Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement. J. Am. Soc. Nephrol. 16, 1177\u20131183 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR14","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","volume":"41","author":"V Fremeaux-Bacchi","year":"2004","unstructured":"Fremeaux-Bacchi, V. et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J. Med. Genet. 41, e84 (2004).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2010155_CR15","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1681\/ASN.2005010103","volume":"16","author":"D Kavanagh","year":"2005","unstructured":"Kavanagh, D. et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 16, 2150\u20132155 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","volume":"45","author":"D Kavanagh","year":"2008","unstructured":"Kavanagh, D. et al. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol. Immunol. 45, 95\u2013105 (2008).","journal-title":"Mol. Immunol."},{"key":"BFnrneph2010155_CR17","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","volume":"362","author":"M Noris","year":"2003","unstructured":"Noris, M. et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362, 1542\u20131547 (2003).","journal-title":"Lancet"},{"key":"BFnrneph2010155_CR18","doi-asserted-by":"publisher","first-page":"12966","DOI":"10.1073\/pnas.2135497100","volume":"100","author":"A Richards","year":"2003","unstructured":"Richards, A. et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl Acad. Sci. USA 100, 12966\u201312971 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2010155_CR19","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1681\/ASN.2005101051","volume":"17","author":"V Fremeaux-Bacchi","year":"2006","unstructured":"Fremeaux-Bacchi, V. et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 17, 2017\u20132025 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1073\/pnas.0603420103","volume":"104","author":"E Goicoechea de Jorge","year":"2007","unstructured":"Goicoechea de Jorge, E. et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc. Natl Acad. Sci. USA 104, 240\u2013245 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2010155_CR21","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1182\/blood-2009-01-197640","volume":"114","author":"LT Roumenina","year":"2009","unstructured":"Roumenina, L. T. et al. Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood 114, 2837\u20132845 (2009).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR22","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","volume":"112","author":"V Fr\u00e9meaux-Bacchi","year":"2008","unstructured":"Fr\u00e9meaux-Bacchi, V. et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112, 4948\u20134952 (2008).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye, M. et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 361, 345\u2013357 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1681\/ASN.2004050380","volume":"16","author":"MA Dragon-Durey","year":"2005","unstructured":"Dragon-Durey, M. A. et al. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 16, 555\u2013563 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","volume":"111","author":"M J\u00f3zsi","year":"2008","unstructured":"J\u00f3zsi, M. et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency. Blood 111, 1512\u20131514 (2008).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR26","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","volume":"110","author":"M J\u00f3zsi","year":"2007","unstructured":"J\u00f3zsi, M. et al. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood 110, 1516\u20131518 (2007).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR27","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","volume":"114","author":"C Abarrategui-Garrido","year":"2009","unstructured":"Abarrategui-Garrido, C., Mart\u00ednez-Barricarte, R., L\u00f3pez-Trascasa, M., de C\u00f3rdoba, S. R. & S\u00e1nchez-Corral, P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 114, 4261\u20134271 (2009).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","volume":"115","author":"I Moore","year":"2010","unstructured":"Moore, I. et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in, CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 115, 379\u2013387 (2010).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddi066","volume":"14","author":"J Esparza-Gordillo","year":"2005","unstructured":"Esparza-Gordillo, J. et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum. Mol. Genet. 14, 703\u2013712 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2010155_CR30","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.molimm.2005.11.008","volume":"43","author":"J Esparza-Gordillo","year":"2006","unstructured":"Esparza-Gordillo, J. et al. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree. Mol. Immunol. 43, 1769\u20131775 (2006).","journal-title":"Mol. Immunol."},{"key":"BFnrneph2010155_CR31","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jmg.2005.030783","volume":"42","author":"V Fremeaux-Bacchi","year":"2005","unstructured":"Fremeaux-Bacchi, V. et al. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J. Med. Genet. 42, 852\u2013856 (2005).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2010155_CR32","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1600-6143.2009.02647.x","volume":"9","author":"JM Cruzado","year":"2009","unstructured":"Cruzado, J. M. et al. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP. Am. J. Transplant. 9, 1477\u20131483 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR33","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","volume":"8","author":"M Le Quintrec","year":"2008","unstructured":"Le Quintrec, M. et al. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am. J. Transplant. 8, 1694\u20131701 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1681\/ASN.2007080923","volume":"19","author":"R Martinez-Barricarte","year":"2008","unstructured":"Martinez-Barricarte, R. et al. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 19, 639\u2013646 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR35","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.4049\/jimmunol.180.9.6385","volume":"180","author":"AM Blom","year":"2008","unstructured":"Blom, A. M. et al. A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity. J. Immunol. 180, 6385\u20136391 (2008).","journal-title":"J. Immunol."},{"key":"BFnrneph2010155_CR36","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","volume":"12","author":"J Caprioli","year":"2003","unstructured":"Caprioli, J. et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum. Mol. Genet. 12, 3385\u20133395 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2010155_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/humu.20435","volume":"28","author":"RE Saunders","year":"2007","unstructured":"Saunders, R. E. et al. The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Hum. Mutat. 28, 222\u2013234 (2007).","journal-title":"Hum. Mutat."},{"key":"BFnrneph2010155_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/jmg.2008.064766","volume":"46","author":"MA Dragon-Durey","year":"2009","unstructured":"Dragon-Durey, M. A. et al. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J. Med. Genet. 46, 447\u2013450 (2009).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2010155_CR39","unstructured":"FH-aHUS Mutation Database [online] , (2010)."},{"key":"BFnrneph2010155_CR40","unstructured":"Jablonski, M. et al. Kidney transplant outcome in atypical hemolytic uremic syndrome: the French experience. Am. Soc. Nephrol. Abstract #F-PO2074 (2009)."},{"key":"BFnrneph2010155_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/humu.9408","volume":"27","author":"S Heinen","year":"2006","unstructured":"Heinen, S. et al. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum. Mutat. 27, 292\u2013293 (2006).","journal-title":"Hum. Mutat."},{"key":"BFnrneph2010155_CR42","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","volume":"3","author":"JP Venables","year":"2006","unstructured":"Venables, J. P. et al. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med. 3, e431 (2006).","journal-title":"PLoS Med."},{"key":"BFnrneph2010155_CR43","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","volume":"3","author":"PF Zipfel","year":"2007","unstructured":"Zipfel, P. F. et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 3, e41 (2007).","journal-title":"PLoS Genet."},{"key":"BFnrneph2010155_CR44","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","volume":"114","author":"S Heinen","year":"2009","unstructured":"Heinen, S. et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114, 2439\u20132447 (2009).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/01.TP.0000085083.74065.1B","volume":"76","author":"MA Artz","year":"2003","unstructured":"Artz, M. A., Steenbergen, E. J., Hoitsma, A. J., Monnens, L. A. & Wetzels, J. F. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections. Transplantation 76, 821\u2013826 (2003).","journal-title":"Transplantation"},{"key":"BFnrneph2010155_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00005792-200003000-00003","volume":"79","author":"A Lahlou","year":"2000","unstructured":"Lahlou, A. et al. Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coop\u00e9ratif de l'Ile-de-France (GCIF). Medicine (Baltimore) 79, 90\u2013102 (2000).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph2010155_CR47","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/00007890-200108270-00033","volume":"72","author":"A Quan","year":"2001","unstructured":"Quan, A., Sullivan, E. K. & Alexander, S. R. Recurrence of hemolytic uremic syndrome after renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 72, 742\u2013745 (2001).","journal-title":"Transplantation"},{"key":"BFnrneph2010155_CR48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","volume":"12","author":"C Loirat","year":"2008","unstructured":"Loirat, C. & Fremeaux-Bacchi, V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr. Transplant. 12, 619\u2013629 (2008).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph2010155_CR49","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1681\/ASN.2008080906","volume":"20","author":"JM Saland","year":"2009","unstructured":"Saland, J. M., Ruggenenti, P. & Remuzzi, G. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 20, 940\u2013949 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/ndt\/gfp388","volume":"25","author":"S Strobel","year":"2010","unstructured":"Strobel, S. et al. Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome. Nephrol. Dial. Transplant. 25, 136\u2013144 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010155_CR51","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/ndt\/gfn063","volume":"23","author":"T Kwon","year":"2008","unstructured":"Kwon, T. et al. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome. Nephrol. Dial. Transplant. 23, 2088\u20132090 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010155_CR52","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1600-6143.2009.02586.x","volume":"9","author":"M Le Quintrec","year":"2009","unstructured":"Le Quintrec, M. et al. Anti-factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome. Am. J. Transplant. 9, 1223\u20131229 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1600-6143.2009.02870.x","volume":"10","author":"AM Waters","year":"2010","unstructured":"Waters, A. M. et al. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. Am. J. Transplant. 10, 168\u2013172 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.ajkd.2008.06.027","volume":"53","author":"MR Chan","year":"2009","unstructured":"Chan, M. R. et al. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Am. J. Kidney Dis. 53, 321\u2013326 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010155_CR55","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00467-006-0320-2","volume":"22","author":"J Geelen","year":"2007","unstructured":"Geelen, J. et al. A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome. Pediatr. Nephrol. 22, 371\u2013375 (2007).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010155_CR56","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","volume":"44","author":"SC Nilsson","year":"2007","unstructured":"Nilsson, S. C. et al. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol. Immunol. 44, 1835\u20131844 (2007).","journal-title":"Mol. Immunol."},{"key":"BFnrneph2010155_CR57","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00467-009-1188-8","volume":"24","author":"JC Davin","year":"2009","unstructured":"Davin, J. C. et al. Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome. Pediatr. Nephrol. 24, 1757\u20131760 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010155_CR58","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/j.1600-6143.2007.01888.x","volume":"7","author":"V Fr\u00e9meaux-Bacchi","year":"2007","unstructured":"Fr\u00e9meaux-Bacchi, V. et al. Recurrence of HUS due to CD46\/MCP mutation after renal transplantation: a role for endothelial microchimerism. Am. J. Transplant. 7, 2047\u20132051 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR59","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1172\/JCI112225","volume":"76","author":"H Ishii","year":"1985","unstructured":"Ishii, H. & Majerus, P. W. Thrombomodulin is present in human plasma and urine. J. Clin. Invest. 76, 2178\u20132181 (1985).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2010155_CR60","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nm0602-582","volume":"8","author":"JR Pratt","year":"2002","unstructured":"Pratt, J. R., Basheer, S. A. & Sacks, S. H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8, 582\u2013587 (2002).","journal-title":"Nat. Med."},{"key":"BFnrneph2010155_CR61","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1111\/j.1600-6143.2006.01427.x","volume":"6","author":"X Zheng","year":"2006","unstructured":"Zheng, X. et al. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am. J. Transplant. 6, 2099\u20132108 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR62","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1053\/ajkd.2000.17690","volume":"36","author":"PT Pham","year":"2000","unstructured":"Pham, P. T. et al. Cyclosporine and tacrolimus-associated thrombotic microangiopathy. Am. J. Kidney Dis. 36, 844\u2013850 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010155_CR63","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","volume":"42","author":"JC Reynolds","year":"2003","unstructured":"Reynolds, J. C., Agodoa, L. Y., Yuan, C. M. & Abbott, K. C. Thrombotic microangiopathy after renal transplantation in the United States. Am. J. Kidney Dis. 42, 1058\u20131068 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010155_CR64","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","volume":"55","author":"A Zarifian","year":"1999","unstructured":"Zarifian, A., Meleg-Smith, S., O'Donovan, R., Tesi, R. J. & Batuman, V. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int. 55, 2457\u20132466 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph2010155_CR65","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s00467-006-0392-z","volume":"22","author":"MC Hastings","year":"2007","unstructured":"Hastings, M. C. et al. Diagnosis of de novo localized thrombotic microangiopathy by surveillance biopsy. Pediatr. Nephrol. 22, 742\u2013746 (2007).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010155_CR66","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1046\/j.1523-1755.2002.00543.x","volume":"62","author":"P Ruggenenti","year":"2002","unstructured":"Ruggenenti, P. Post-transplant hemolytic-uremic syndrome. Kidney Int. 62, 1093\u20131104 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph2010155_CR67","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","volume":"41","author":"J Schwimmer","year":"2003","unstructured":"Schwimmer, J., Nadasdy, T. A., Spitalnik, P. F., Kaplan, K. L. & Zand, M. S. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am. J. Kidney Dis. 41, 471\u2013479 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010155_CR68","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti, P., Noris, M. & Remuzzi, G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 60, 831\u2013846 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2010155_CR69","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/TP.0b013e3181891d8b","volume":"86","author":"RS Al-Lamki","year":"2008","unstructured":"Al-Lamki, R. S., Bradley, J. R. & Pober, J. S. Endothelial cells in allograft rejection. Transplantation 86, 1340\u20131348 (2008).","journal-title":"Transplantation"},{"key":"BFnrneph2010155_CR70","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1046\/j.1600-6143.2003.00222.x","volume":"3","author":"V Karthikeyan","year":"2003","unstructured":"Karthikeyan, V., Parasuraman, R., Shah, V., Vera, E. & Venkat, K. K. Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation. Am. J. Transplant. 3, 1289\u20131294 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR71","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","volume":"10","author":"AA Satoskar","year":"2010","unstructured":"Satoskar, A. A. et al. De novo thrombotic microangiopathy in renal allograft biopsies\u2014role of antibody-mediated rejection. Am. J. Transplant. 10, 1804\u20131811 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR72","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1111\/j.1600-6143.2010.03233.x","volume":"10","author":"G Canaud","year":"2010","unstructured":"Canaud, G. et al. Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am. J. Transplant. 10, 2051\u20132060 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR73","doi-asserted-by":"publisher","first-page":"F351","DOI":"10.1152\/ajprenal.90276.2008","volume":"295","author":"O Kwon","year":"2008","unstructured":"Kwon, O., Hong, S. M., Sutton, T. A. & Temm, C. J. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 295, F351\u2013F359 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2010155_CR74","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0272-6386(99)70085-5","volume":"34","author":"J Waiser","year":"1999","unstructured":"Waiser, J., Budde, K., Rudolph, B., Ortner, M. A. & Neumayer, H. H. De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection. Am. J. Kidney Dis. 34, 556\u2013559 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010155_CR75","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1053\/j.ajkd.2004.09.012","volume":"45","author":"KH Olie","year":"2005","unstructured":"Olie, K. H. et al. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir. Am. J. Kidney Dis. 45, e12\u2013e15 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010155_CR76","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/j.1600-6143.2008.02244.x","volume":"8","author":"MR Ardalan","year":"2008","unstructured":"Ardalan, M. R., Shoja, M. M., Tubbs, R. S., Esmaili, H. & Keyvani, H. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection. Am. J. Transplant. 8, 1340\u20131344 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR77","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","volume":"11","author":"L Murer","year":"2000","unstructured":"Murer, L. et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J. Am. Soc. Nephrol. 11, 1132\u20131137 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR78","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens, M., Kuypers, D. R. & Sarwal, M. Calcineurin inhibitor nephrotoxicity. Clin. J. Am. Soc. Nephrol. 4, 481\u2013508 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR79","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ncpneph0225","volume":"2","author":"P Liptak","year":"2006","unstructured":"Liptak, P. & Ivanyi, B. Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat. Clin. Pract. Nephrol. 2, 398\u2013404 (2006).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"BFnrneph2010155_CR80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5414\/CNP67335","volume":"67","author":"C Ponticelli","year":"2007","unstructured":"Ponticelli, C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin. Nephrol. 67, 335\u2013340 (2007).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2010155_CR81","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1600-6143.2006.01781.x","volume":"7","author":"KA Andreoni","year":"2007","unstructured":"Andreoni, K. A., Brayman, K. L., Guidinger, M. K., Sommers, C. M. & Sung, R. S. Kidney and pancreas transplantation in the United States, 1996\u20132005. Am. J. Transplant. 7, 1359\u20131375 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR82","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00007890-198707000-00027","volume":"44","author":"J English","year":"1987","unstructured":"English, J., Evan, A., Houghton, D. C. & Bennett, W. M. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 44, 135\u2013141 (1987).","journal-title":"Transplantation"},{"key":"BFnrneph2010155_CR83","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI116440","volume":"91","author":"DM Lanese","year":"1993","unstructured":"Lanese, D. M. & Conger, J. D. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J. Clin. Invest. 91, 2144\u20132149 (1993).","journal-title":"J. Clin. Invest."},{"issue":"Suppl.","key":"BFnrneph2010155_CR84","first-page":"I214","volume":"114","author":"D Ramzy","year":"2006","unstructured":"Ramzy, D. et al. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine. Circulation 114 (Suppl.), I214\u2013I219 (2006).","journal-title":"Circulation"},{"key":"BFnrneph2010155_CR85","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1111\/j.1600-6143.2008.02399.x","volume":"8","author":"G Al-Massarani","year":"2008","unstructured":"Al-Massarani, G. et al. Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. Am. J. Transplant. 8, 2360\u20132367 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR86","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1600-6143.2004.00428.x","volume":"4","author":"MC Fortin","year":"2004","unstructured":"Fortin, M. C. et al. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am. J. Transplant. 4, 946\u2013952 (2004).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR87","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1034\/j.1600-6143.2003.00051.x","volume":"3","author":"M Robson","year":"2003","unstructured":"Robson, M., C\u00f4te, I., Abbs, I., Koffman, G. & Goldsmith, D. Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage? Am. J. Transplant. 3, 324\u2013327 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR88","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","volume":"5","author":"H Sartelet","year":"2005","unstructured":"Sartelet, H. et al. Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys. Am. J. Transplant. 5, 2441\u20132447 (2005).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR89","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina, V. et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129\u20131136 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR90","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/j.1600-6143.2006.01433.x","volume":"6","author":"SG Miriuka","year":"2006","unstructured":"Miriuka, S. G. et al. mTOR inhibition induces endothelial progenitor cell death. Am. J. Transplant. 6, 2069\u20132079 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR91","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1161\/CIRCULATIONAHA.107.718874","volume":"117","author":"J Simmonds","year":"2008","unstructured":"Simmonds, J. et al. Endothelial dysfunction and cytomegalovirus replication in pediatric heart transplantation. Circulation 117, 2657\u20132661 (2008).","journal-title":"Circulation"},{"key":"BFnrneph2010155_CR92","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1182\/blood-2007-08-107730","volume":"111","author":"CA Bolovan-Fritts","year":"2008","unstructured":"Bolovan-Fritts, C. A. & Spector, S. A. Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood 111, 175\u2013182 (2008).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR93","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMoa010319","volume":"345","author":"T Petrogiannis-Haliotis","year":"2001","unstructured":"Petrogiannis-Haliotis, T. et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N. Engl. J. Med. 345, 1250\u20131255 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR94","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","volume":"148","author":"CM Taylor","year":"2010","unstructured":"Taylor, C. M., Machin, S., Wigmore, S. J. & Goodship, T. H. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Br. J. Haematol. 148, 37\u201347 (2010).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph2010155_CR95","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","volume":"111","author":"CJ Fang","year":"2008","unstructured":"Fang, C. J. et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 111, 624\u2013632 (2008).","journal-title":"Blood"},{"key":"BFnrneph2010155_CR96","unstructured":"The European Society for Paediatric Nephrology [online] , (2010)."},{"key":"BFnrneph2010155_CR97","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1399-0004.1995.tb03952.x","volume":"47","author":"MM N\u00f6then","year":"1995","unstructured":"N\u00f6then, M. M. & Dewald, G. Dinucleotide repeat polymorphism at the human CD59 locus. Clin. Genet. 47, 165\u2013166 (1995).","journal-title":"Clin. Genet."},{"key":"BFnrneph2010155_CR98","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1084\/jem.166.1.246","volume":"166","author":"J Rey-Campos","year":"1987","unstructured":"Rey-Campos, J., Rubinstein, P. & Rodriguez de Cordoba, S. Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans. J. Exp. Med. 166, 246\u2013252 (1987).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2010155_CR99","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1056\/NEJMoa052825","volume":"354","author":"KM Brown","year":"2006","unstructured":"Brown, K. M. et al. Influence of donor C3 allotype on late renal-transplantation outcome. N. Engl. J. Med. 354, 2014\u20132023 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR100","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJMoa0801861","volume":"360","author":"M Varagunam","year":"2009","unstructured":"Varagunam, M., Yaqoob, M. M., D\u00f6hler, B. & Opelz, G. C3 polymorphisms and allograft outcome in renal transplantation. N. Engl. J. Med. 360, 874\u2013880 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR101","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1084\/jem.20041967","volume":"201","author":"PS Heeger","year":"2005","unstructured":"Heeger, P. S. et al. Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201, 1523\u20131530 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2010155_CR102","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.20040863","volume":"201","author":"J Liu","year":"2005","unstructured":"Liu, J. et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201, 567\u2013577 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2010155_CR103","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1111\/j.1600-6143.2009.02723.x","volume":"9","author":"H Raedler","year":"2009","unstructured":"Raedler, H., Yang, M., Lalli, P. N., Medof, M. E. & Heeger, P. S. Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am. J. Transplant. 9, 1784\u20131795 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR104","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ki.2009.491","volume":"77","author":"MB Vieyra","year":"2009","unstructured":"Vieyra, M. B. & Heeger, P. S. Novel aspects of complement in kidney injury. Kidney Int. 77, 495\u2013499 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2010155_CR105","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1600-6143.2005.01184.x","volume":"6","author":"O Oyen","year":"2006","unstructured":"Oyen, O. et al. Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy\/hemolytic uremic syndrome. Am. J. Transplant. 6, 412\u2013418 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR106","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/ndt\/11.9.1810","volume":"11","author":"PJ Conlon","year":"1996","unstructured":"Conlon, P. J. et al. Renal transplantation in adults with thrombotic thrombocytopenic purpura\/haemolytic-uraemic syndrome. Nephrol. Dial. Transplant. 11, 1810\u20131814 (1996).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010155_CR107","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/ndt\/12.7.1425","volume":"12","author":"RB Miller","year":"1997","unstructured":"Miller, R. B. et al. Recurrence of haemolytic-uraemic syndrome in renal transplants: a single-centre report. Nephrol. Dial. Transplant. 12, 1425\u20131430 (1997).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010155_CR108","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1600-6143.2008.02482.x","volume":"9","author":"N Ashman","year":"2009","unstructured":"Ashman, N. et al. Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy. Am. J. Transplant. 9, 424\u2013427 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR109","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1097\/TP.0b013e3181a991ca","volume":"87","author":"K Midtvedt","year":"2009","unstructured":"Midtvedt, K., Bitter, J., D\u00f8rje, C., Bj\u00f8rneklett, R. & Holdaas, H. Belatacept as immunosuppression in patient with recurrence of hemolytic uremic syndrome after renal transplantation. Transplantation 87, 1901\u20131903 (2009).","journal-title":"Transplantation"},{"key":"BFnrneph2010155_CR110","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.ajkd.2009.08.011","volume":"55","author":"JC Davin","year":"2010","unstructured":"Davin, J. C. et al. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. Am. J. Kidney Dis. 55, 708\u2013711 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010155_CR111","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00467-008-0833-y","volume":"23","author":"JC Davin","year":"2008","unstructured":"Davin, J. C., Strain, L. & Goodship, T. H. Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation. Pediatr. Nephrol. 23, 1517\u20131521 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010155_CR112","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1093\/ndt\/gfp377","volume":"24","author":"P Hirt-Minkowski","year":"2009","unstructured":"Hirt-Minkowski, P. et al. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Nephrol. Dial. Transplant. 24, 3548\u20133551 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010155_CR113","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1111\/j.1600-6143.2009.02817.x","volume":"9","author":"V Chatelet","year":"2009","unstructured":"Chatelet, V., Fr\u00e9meaux-Bacchi, V., Lobbedez, T., Ficheux, M. & Hurault de Ligny, B. Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome. Am. J. Transplant. 9, 2644\u20132645 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR114","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1053\/j.ajkd.2009.12.026","volume":"55","author":"O Boyer","year":"2010","unstructured":"Boyer, O. et al. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies. Am. J. Kidney Dis. 55, 923\u2013927 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010155_CR115","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00467-003-1371-2","volume":"19","author":"HI Cheong","year":"2004","unstructured":"Cheong, H. I. et al. Attempted treatment of factor H deficiency by liver transplantation. Pediatr. Nephrol. 19, 454\u2013458 (2004).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010155_CR116","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","volume":"359","author":"G Remuzzi","year":"2002","unstructured":"Remuzzi, G. et al. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 359, 1671\u20131672 (2002).","journal-title":"Lancet"},{"key":"BFnrneph2010155_CR117","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/j.1600-6143.2005.00783.x","volume":"5","author":"G Remuzzi","year":"2005","unstructured":"Remuzzi, G. et al. Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. Am. J. Transplant. 5, 1146\u20131150 (2005).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR118","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-6143.2007.02029.x","volume":"8","author":"H Jalanko","year":"2008","unstructured":"Jalanko, H. et al. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am. J. Transplant. 8, 216\u2013221 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR119","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/j.1600-6143.2006.01375.x","volume":"6","author":"JM Saland","year":"2006","unstructured":"Saland, J. M. et al. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am. J. Transplant. 6, 1948\u20131952 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010155_CR120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2215\/CJN.02170508","volume":"4","author":"JM Saland","year":"2009","unstructured":"Saland, J. M. et al. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin. J. Am. Soc. Nephrol. 4, 201\u2013206 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR121","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(09)60001-5","volume":"373","author":"C Parker","year":"2009","unstructured":"Parker, C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet 373, 759\u2013767 (2009).","journal-title":"Lancet"},{"key":"BFnrneph2010155_CR122","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1056\/NEJMc0809959","volume":"360","author":"RA Gruppo","year":"2009","unstructured":"Gruppo, R. A. & Rother, R. P. Eculizumab for congenital atypical hemolytic-uremic syndrome. N. Engl. J. Med. 360, 544\u2013546 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR123","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMc0808527","volume":"360","author":"J N\u00fcrnberger","year":"2009","unstructured":"N\u00fcrnberger, J. et al. Eculizumab for atypical hemolytic-uremic syndrome. N. Engl. J. Med. 360, 542\u2013544 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR124","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/TP.0b013e3181ccd80d","volume":"89","author":"CF Larrea","year":"2010","unstructured":"Larrea, C. F. et al. Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation. Transplantation 89, 903\u2013904 (2010).","journal-title":"Transplantation"},{"key":"BFnrneph2010155_CR125","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMc1001060","volume":"362","author":"LB Zimmerhackl","year":"2010","unstructured":"Zimmerhackl, L. B. et al. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 362, 1746\u20131748 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR126","unstructured":"Alexion clinical trials [online] , (2010)."},{"key":"BFnrneph2010155_CR127","unstructured":"LFB Biotechnologies [online] , (2010)."},{"key":"BFnrneph2010155_CR128","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/bmt.2009.242","volume":"45","author":"M Sakai","year":"2009","unstructured":"Sakai, M., Ikezoe, T., Bandobashi, K., Togitani, K. & Yokoyama, A. Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin. Bone Marrow Transplant. 45, 803\u2013805 (2009).","journal-title":"Bone Marrow Transplant."},{"key":"BFnrneph2010155_CR129","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrd3011","volume":"9","author":"E Wagner","year":"2010","unstructured":"Wagner, E. & Frank, M. M. Therapeutic potential of complement modulation. Nat. Rev. Drug Discov. 9, 43\u201356 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrneph2010155_CR130","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport, M. J. Complement. First of two parts. N. Engl. J. Med. 344, 1058\u20131066 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010155_CR131","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1681\/ASN.2005020137","volume":"16","author":"N Eto","year":"2005","unstructured":"Eto, N. et al. Protection of endothelial cells by dextran sulfate in rats with thrombotic microangiopathy. J. Am. Soc. Nephrol. 16, 2997\u20133005 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010155_CR132","first-page":"LB17","volume-title":"5th Congress of the International Pediatric Transplantation Association, Istanbul","author":"TC Jungraithmayr","year":"2009","unstructured":"Jungraithmayr, T. C. et al. Successful renal transplantation in a 10-year old boy with factor H associated hemolytic uremic syndrome (aHUS) with plasmapheresis and eculizumab. 5th Congress of the International Pediatric Transplantation Association, Istanbul, LB17 (2009)."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.155","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T08:05:00Z","timestamp":1685865900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2010.155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["BFnrneph2010155"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2010.155","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]}}}